Calphostin C inhibits endothelial cell proliferation and selectively modulates cell-surface marker expression.
Edwards
B D
BD
Department of Medicine, University of Manchester, U.K.
Slevin
M A
MA
Dickson
A J
AJ
Ager
A
A
Ballardie
F W
FW
D002448:Cell Adhesion; D015815:Cell Adhesion Molecules / Q000096:biosynthesis*; D002455:Cell Division / Q000187:drug effects*; D002460:Cell Line; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D006680:HLA Antigens / Q000096:biosynthesis*; D015234:HLA-A Antigens / Q000096:biosynthesis; D015235:HLA-B Antigens / Q000096:biosynthesis; D015236:HLA-C Antigens / Q000096:biosynthesis; D006684:HLA-DR Antigens / Q000096:biosynthesis*; D006801:Humans; D018799:Intercellular Adhesion Molecule-1; D009281:Naphthalenes; D011083:Polycyclic Compounds / Q000494:pharmacology*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*
D015815:Cell Adhesion Molecules; D006680:HLA Antigens; D015234:HLA-A Antigens; D015235:HLA-B Antigens; D015236:HLA-C Antigens; D006684:HLA-DR Antigens; D009281:Naphthalenes; D011083:Polycyclic Compounds; D018799:Intercellular Adhesion Molecule-1; D011493:Protein Kinase C; C058819:calphostin C